Exelixis (EXEL) Cash & Equivalents (2010 - 2026)

Exelixis' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $226.2 million for Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 23.07% year-over-year to $226.2 million in Q2 2026; TTM through Apr 2026 was $226.2 million, a 23.07% increase from a year earlier, with the FY2026 full-year figure at $482.5 million, up 121.96% from the prior year.
• Cash & Equivalents declined to $226.2 million in Q2 2026 per EXEL's latest filing, from $482.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $723.3 million in Q2 2022 and bottomed at $164.4 million in Q3 2025.
• The 5-year median for Cash & Equivalents is $376.3 million (2025), against an average of $385.8 million.
• Across the five-year window, Cash & Equivalents sank 57.27% in 2024 and soared 121.96% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $501.2 million in 2022, then sank by 47.53% to $263.0 million in 2023, then slipped by 1.77% to $258.3 million in 2024, then surged by 45.66% to $376.3 million in 2025, then sank by 39.9% to $226.2 million in 2026.
• Per Business Quant, the three latest EXEL Cash & Equivalents figures stand at $226.2 million (Q2 2026), $482.5 million (Q1 2026), and $376.3 million (Q4 2025).